We found that the tumor stage (T stage), node stage (N stage), metastasis stage (M stage), clinical stage, ER status, PR status, HER2 status, and the LumB subtype could be divided into 2 groups with significant prognostic differences based on the risk score (P < 0.05, Figure 4). The gene discussed is ERBB2; the disease is neoplasm.